Structural Basis of Resistance of Helicobacterpylori DnaK to Antimicrobial Peptide Pyrrhocoricin
Bacterial molecular chaperone DnaK plays an essential role in protein folding, stress response and transmembrane targeting of proteins. DnaKs from many bacterial species, including Escherichia coli, Salmonella typhimurium and Haemophilus infleunzae are the molecular targets for the insect-derived antimicrobial peptide pyrrhocoricin. Pyrrhocoricin-like peptides bind in the substrate recognition tunnel. Despite the high degree of crossspecies sequence conservation in the substrate-binding tunnel, some bacteria are not sensitive to pyrrhocoricin. This work addresses the molecular mechanism of resistance of Helicobacter pylori DnaK to pyrrhocoricin. Homology modelling, structural and sequence analysis identify a single aminoacid substitution at the interface between the lid and the β-sandwich subdomains of the DnaK substrate-binding domain as the major determinant for its resistance.
[1] A. Covacci, J. L. Telford, G. Del Giudice et al., "Helicobacter
pylori virulence and genetic geography," Science, vol. 284, no.
5418, pp. 1328-33, May 21, 1999.
[2] B. J. Marshall, and J. R. Warren, "Unidentified curved bacilli in
the stomach of patients with gastritis and peptic ulceration,"
Lancet, vol. 1, no. 8390, pp. 1311-5, Jun 16, 1984.
[3] R. M. Peek, Jr., and M. J. Blaser, "Helicobacter pylori and
gastrointestinal tract adenocarcinomas," Nat Rev Cancer, vol. 2,
no. 1, pp. 28-37, Jan, 2002.
[4] A. C. Ford, B. C. Delaney, D. Forman et al., "Eradication therapy
for peptic ulcer disease in Helicobacter pylori positive patients,"
Cochrane Database Syst Rev, no. 2, pp. CD003840, 2006.
[5] N. Uemura, T. Mukai, S. Okamoto et al., "Effect of Helicobacter
pylori eradication on subsequent development of cancer after
endoscopic resection of early gastric cancer," Cancer Epidemiol
Biomarkers Prev, vol. 6, no. 8, pp. 639-42, Aug, 1997.
[6] G. Treiber, S. Ammon, E. Schneider et al.,
"Amoxicillin/metronidazole/omeprazole/clarithromycin: a new,
short quadruple therapy for Helicobacter pylori eradication,"
Helicobacter, vol. 3, no. 1, pp. 54-8, Mar, 1998.
[7] N. Broutet, S. Tchamgoue, E. Pereira et al., "Risk factors for
failure of Helicobacter pylori therapy--results of an individual data
analysis of 2751 patients," Aliment Pharmacol Ther, vol. 17, no. 1,
pp. 99-109, Jan, 2003.
[8] G. Kragol, S. Lovas, G. Varadi et al., "The antibacterial peptide
pyrrhocoricin inhibits the ATPase actions of DnaK and prevents
chaperone-assisted protein folding," Biochemistry, vol. 40, no. 10,
pp. 3016-26, Mar 13, 2001.
[9] L. Otvos, Jr., K. Bokonyi, I. Varga et al., "Insect peptides with
improved protease-resistance protect mice against bacterial
infection," Protein Sci, vol. 9, no. 4, pp. 742-9, Apr, 2000.
[10] M. P. Mayer, and B. Bukau, "Hsp70 chaperones: cellular functions
and molecular mechanism," Cell Mol Life Sci, vol. 62, no. 6, pp.
670-84, Mar, 2005.
[11] M. Liebscher, and A. Roujeinikova, "Allosteric coupling between
the lid and interdomain linker in DnaK revealed by inhibitor
binding studies," J Bacteriol, vol. 191, no. 5, pp. 1456-62, Mar,
2009.
[12] G. Kragol, R. Hoffmann, M. A. Chattergoon et al., "Identification
of crucial residues for the antibacterial activity of the proline-rich
peptide, pyrrhocoricin," Eur J Biochem, vol. 269, no. 17, pp. 4226-
37, Sep, 2002.
[13] A. Sali, and T. L. Blundell, "Comparative protein modelling by
satisfaction of spatial restraints," J Mol Biol, vol. 234, no. 3, pp.
779-815, Dec 5, 1993.
[14] A. Fiser, R. K. Do, and A. Sali, "Modeling of loops in protein
structures," Protein Sci, vol. 9, no. 9, pp. 1753-73, Sep, 2000.
[15] M. J. Sippl, "Recognition of errors in three-dimensional structures
of proteins," Proteins, vol. 17, no. 4, pp. 355-62, Dec, 1993.
[16] M. Wiederstein, and M. J. Sippl, "ProSA-web: interactive web
service for the recognition of errors in three-dimensional structures
of proteins," Nucleic Acids Res, vol. 35, no. Web Server issue, pp.
W407-10, Jul, 2007.
[17] B. Wallner, and A. Elofsson, "Can correct protein models be
identified?," Protein Sci, vol. 12, no. 5, pp. 1073-86, May, 2003.
[18] J. U. Bowie, R. Luthy, and D. Eisenberg, "A method to identify
protein sequences that fold into a known three-dimensional
structure," Science, vol. 253, no. 5016, pp. 164-70, Jul 12, 1991.
[19] N. Guex, and M. C. Peitsch, "SWISS-MODEL and the Swiss-
PdbViewer: an environment for comparative protein modeling,"
Electrophoresis, vol. 18, no. 15, pp. 2714-23, Dec, 1997.
[20] W. L. DeLano, "The PyMOL Molecular Graphics System: Version
0.90 (DeLano Scientific, Palo Alto, CA)," 2003.
[21] X. Zhu, X. Zhao, W. F. Burkholder et al., "Structural analysis of
substrate binding by the molecular chaperone DnaK," Science, vol.
272, no. 5268, pp. 1606-14, Jun 14, 1996.
[22] P. Emsley, and K. Cowtan, "Coot: model-building tools for
molecular graphics," Acta Crystallogr D Biol Crystallogr, vol. 60,
no. Pt 12 Pt 1, pp. 2126-32, Dec, 2004.
[23] A. Roujeinikova, "Crystal structure of the cell wall anchor domain
of MotB, a stator component of the bacterial flagellar motor:
implications for peptidoglycan recognition," Proc Natl Acad Sci U
S A, vol. 105, no. 30, pp. 10348-53, Jul 29, 2008.
[1] A. Covacci, J. L. Telford, G. Del Giudice et al., "Helicobacter
pylori virulence and genetic geography," Science, vol. 284, no.
5418, pp. 1328-33, May 21, 1999.
[2] B. J. Marshall, and J. R. Warren, "Unidentified curved bacilli in
the stomach of patients with gastritis and peptic ulceration,"
Lancet, vol. 1, no. 8390, pp. 1311-5, Jun 16, 1984.
[3] R. M. Peek, Jr., and M. J. Blaser, "Helicobacter pylori and
gastrointestinal tract adenocarcinomas," Nat Rev Cancer, vol. 2,
no. 1, pp. 28-37, Jan, 2002.
[4] A. C. Ford, B. C. Delaney, D. Forman et al., "Eradication therapy
for peptic ulcer disease in Helicobacter pylori positive patients,"
Cochrane Database Syst Rev, no. 2, pp. CD003840, 2006.
[5] N. Uemura, T. Mukai, S. Okamoto et al., "Effect of Helicobacter
pylori eradication on subsequent development of cancer after
endoscopic resection of early gastric cancer," Cancer Epidemiol
Biomarkers Prev, vol. 6, no. 8, pp. 639-42, Aug, 1997.
[6] G. Treiber, S. Ammon, E. Schneider et al.,
"Amoxicillin/metronidazole/omeprazole/clarithromycin: a new,
short quadruple therapy for Helicobacter pylori eradication,"
Helicobacter, vol. 3, no. 1, pp. 54-8, Mar, 1998.
[7] N. Broutet, S. Tchamgoue, E. Pereira et al., "Risk factors for
failure of Helicobacter pylori therapy--results of an individual data
analysis of 2751 patients," Aliment Pharmacol Ther, vol. 17, no. 1,
pp. 99-109, Jan, 2003.
[8] G. Kragol, S. Lovas, G. Varadi et al., "The antibacterial peptide
pyrrhocoricin inhibits the ATPase actions of DnaK and prevents
chaperone-assisted protein folding," Biochemistry, vol. 40, no. 10,
pp. 3016-26, Mar 13, 2001.
[9] L. Otvos, Jr., K. Bokonyi, I. Varga et al., "Insect peptides with
improved protease-resistance protect mice against bacterial
infection," Protein Sci, vol. 9, no. 4, pp. 742-9, Apr, 2000.
[10] M. P. Mayer, and B. Bukau, "Hsp70 chaperones: cellular functions
and molecular mechanism," Cell Mol Life Sci, vol. 62, no. 6, pp.
670-84, Mar, 2005.
[11] M. Liebscher, and A. Roujeinikova, "Allosteric coupling between
the lid and interdomain linker in DnaK revealed by inhibitor
binding studies," J Bacteriol, vol. 191, no. 5, pp. 1456-62, Mar,
2009.
[12] G. Kragol, R. Hoffmann, M. A. Chattergoon et al., "Identification
of crucial residues for the antibacterial activity of the proline-rich
peptide, pyrrhocoricin," Eur J Biochem, vol. 269, no. 17, pp. 4226-
37, Sep, 2002.
[13] A. Sali, and T. L. Blundell, "Comparative protein modelling by
satisfaction of spatial restraints," J Mol Biol, vol. 234, no. 3, pp.
779-815, Dec 5, 1993.
[14] A. Fiser, R. K. Do, and A. Sali, "Modeling of loops in protein
structures," Protein Sci, vol. 9, no. 9, pp. 1753-73, Sep, 2000.
[15] M. J. Sippl, "Recognition of errors in three-dimensional structures
of proteins," Proteins, vol. 17, no. 4, pp. 355-62, Dec, 1993.
[16] M. Wiederstein, and M. J. Sippl, "ProSA-web: interactive web
service for the recognition of errors in three-dimensional structures
of proteins," Nucleic Acids Res, vol. 35, no. Web Server issue, pp.
W407-10, Jul, 2007.
[17] B. Wallner, and A. Elofsson, "Can correct protein models be
identified?," Protein Sci, vol. 12, no. 5, pp. 1073-86, May, 2003.
[18] J. U. Bowie, R. Luthy, and D. Eisenberg, "A method to identify
protein sequences that fold into a known three-dimensional
structure," Science, vol. 253, no. 5016, pp. 164-70, Jul 12, 1991.
[19] N. Guex, and M. C. Peitsch, "SWISS-MODEL and the Swiss-
PdbViewer: an environment for comparative protein modeling,"
Electrophoresis, vol. 18, no. 15, pp. 2714-23, Dec, 1997.
[20] W. L. DeLano, "The PyMOL Molecular Graphics System: Version
0.90 (DeLano Scientific, Palo Alto, CA)," 2003.
[21] X. Zhu, X. Zhao, W. F. Burkholder et al., "Structural analysis of
substrate binding by the molecular chaperone DnaK," Science, vol.
272, no. 5268, pp. 1606-14, Jun 14, 1996.
[22] P. Emsley, and K. Cowtan, "Coot: model-building tools for
molecular graphics," Acta Crystallogr D Biol Crystallogr, vol. 60,
no. Pt 12 Pt 1, pp. 2126-32, Dec, 2004.
[23] A. Roujeinikova, "Crystal structure of the cell wall anchor domain
of MotB, a stator component of the bacterial flagellar motor:
implications for peptidoglycan recognition," Proc Natl Acad Sci U
S A, vol. 105, no. 30, pp. 10348-53, Jul 29, 2008.
@article{"International Journal of Biological, Life and Agricultural Sciences:62246", author = "Musammat F. Nahar and Anna Roujeinikova", title = "Structural Basis of Resistance of Helicobacterpylori DnaK to Antimicrobial Peptide Pyrrhocoricin", abstract = "Bacterial molecular chaperone DnaK plays an essential role in protein folding, stress response and transmembrane targeting of proteins. DnaKs from many bacterial species, including Escherichia coli, Salmonella typhimurium and Haemophilus infleunzae are the molecular targets for the insect-derived antimicrobial peptide pyrrhocoricin. Pyrrhocoricin-like peptides bind in the substrate recognition tunnel. Despite the high degree of crossspecies sequence conservation in the substrate-binding tunnel, some bacteria are not sensitive to pyrrhocoricin. This work addresses the molecular mechanism of resistance of Helicobacter pylori DnaK to pyrrhocoricin. Homology modelling, structural and sequence analysis identify a single aminoacid substitution at the interface between the lid and the β-sandwich subdomains of the DnaK substrate-binding domain as the major determinant for its resistance.
", keywords = "Helicobacter pylori, molecular chaperone DnaK,pyrrhocoricin, structural biology.", volume = "4", number = "5", pages = "355-4", }
